A signed purchase agreement does not carry a DEA registration from seller to buyer. Federal regulation treats the registration as personal to the registrant, and 21 CFR 1301.52(b) bars assigning or transferring it except with DEA's written consent. A pharmacy sale that treats the DEA number as part of the fixtures risks a gap between closing and the day the buyer can lawfully dispense. Sequencing the buyer's application, the inventory handoff, the records, and the parallel state registration is what keeps that gap from opening.
The Registration Belongs to the Registrant, Not the Business
A buyer acquiring a pharmacy's operating assets applies for its own DEA registration on DEA Form 224, the retail pharmacy application, under its own ownership. The application is reviewed on its own facts; it is not a renewal of the seller's number and inherits none of the seller's history. Most state boards also require a valid state license before DEA will act on the federal application, so the two cannot run as separate tracks. Whether a transaction needs a new registration at all can turn on structure: a stock or membership-interest sale, where the same corporate registrant simply changes owners, is treated differently from an asset sale, where a new entity steps into the registrant's shoes.
Applying Early Enough to Keep Dispensing on Closing Day
The only firm deadline the regulation sets runs against the seller, not the buyer: a registrant transferring its business must notify the DEA Special Agent in Charge at least 14 days before the proposed transfer date, naming both parties, their registration numbers, and whether the business will keep operating at the same address. That 14 days is a floor for the seller's notice, not a target for the buyer's own application. DEA reviews a change-of-ownership application the way it reviews any new pharmacy application, verifying ownership and the location's safeguards, and that process does not compress to fit a closing date chosen for other reasons. The same scrutiny that can turn a routine renewal into a lapsed registration filed too close to a deadline applies with more force to a first-time application tied to a closing. Filing the buyer's application only after signing, rather than as soon as the deal is reasonably certain, is the most common reason a closing outruns the registration behind it.
Transferring the Controlled Substance Inventory
Once DEA has approved the transfer, a complete inventory of the controlled substances changing hands is taken on the date of the transfer itself, under 21 CFR 1304.11, doing double duty as the seller's final inventory and the buyer's opening inventory. Schedule II product cannot simply be handed across the counter: the buyer, as the registrant now receiving the drugs, must issue a DEA Form 222 (or its CSOS electronic equivalent) to the seller, the same order form used for any Schedule II purchase. Schedule III through V product moves with a written record of the drug name, dosage form, strength, quantity and transfer date. Both records, with the day-of-transfer count, are the inventory reconciliation either side would need if DEA ever questioned the stock on hand the week of the sale.
The DEA registration follows the registrant, not the pharmacy. Selling the business does not sell the authority to handle controlled substances along with it.
Records Custody and the State Registration That Moves With It
The seller's controlled substance records for the drugs being transferred do not stay with the seller. Under 21 CFR 1304.04, they pass to the buyer, who becomes responsible for their custody and maintenance from the transfer date forward, for the two-year federal retention period set by 21 U.S.C. 827(b), even though the seller stays answerable for their accuracy before that date. A buyer that treats the acquired file as the seller's problem inherits a recordkeeping gap it did not create but is the one DEA will ask to explain. The same discipline applies to the pharmacy's separate state controlled substance registration, issued by the state board and ordinarily no more transferable than the federal one: a buyer holding a new DEA number but no state-level equivalent can be registered and still unable to dispense. The state application, the DEA application, and the pharmacy license transfer belong on one shared timeline, since a delay in any one can hold up the other two.
Why Early Legal Counsel Is Critical
It is critical that a buyer or seller retain experienced healthcare defense counsel as soon as a pharmacy sale is reasonably certain, not after the purchase agreement is signed. Early legal involvement can confirm which transaction structure actually requires a new DEA registration, get the buyer's application and the parallel state registration moving on a realistic timeline, and build the closing-day inventory and records handoff before it is needed. Waiting until days before closing to start the registration process can turn a routine sale into a forced interruption in dispensing.
How Health Law Alliance Can Help
Health Law Alliance has represented 2,500+ clients over 25+ years, including pharmacies on both sides of a sale who need the DEA registration, the state registration, and the inventory and records handoff sequenced around a closing date. Our DEA defense attorneys work alongside transactional counsel to keep a change of ownership from becoming a registration problem, and represent registrants when DEA questions a prior transfer or denies a new application outright. Contact Health Law Alliance for a free, confidential consultation.
